Immuneering Corporation

• A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

  Phase 1/2, Active, not recruiting, 209 people, Oct 18, 2022

Sources: clinicaltrials.gov

• Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study

  Grants or research support, Jun 15, 2026

Sources: pubmed.ncbi.nlm.nih.gov

• The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease

  Neurobiology of disease, Nov 8, 2016